Moleculin Biotech is trading at $0.42 (5.4%) up today as the stock stabilizes following a sharp multi-day selloff triggered by a deeply discounted $9.3 million public offering.
- The offering, announced July 31, 2026, was priced at $0.75 per share with attached warrants, driving the stock down from above $2.00 to $0.40.
- Today's modest rebound reflects bargain-hunting and stabilization following the heavy dilution shock.